NCT01206075: Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major |
|
|
| Completed | N/A | 20 | Europe | Mozobil, Plerixafor, AMD 3100, AMD3100 | University of Washington, National Heart, Lung, and Blood Institute (NHLBI), George Papanicolaou Hospital, Genzyme, a Sanofi Company | Beta-Thalassemia | 12/12 | 12/14 | | |
